• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Distinct epigenetic signatures between adult-onset and late-onset depression.成年发病型和晚发型抑郁症之间存在明显的表观遗传特征差异。
Sci Rep. 2021 Jan 27;11(1):2296. doi: 10.1038/s41598-021-81758-8.
2
Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validation.利用多重DNA甲基化谱鉴定重度抑郁症的血液诊断生物标志物:发现与验证
Epigenetics. 2015;10(2):135-41. doi: 10.1080/15592294.2014.1003743. Epub 2015 Jan 14.
3
An epigenome-wide methylation study of healthy individuals with or without depressive symptoms.具有或不具有抑郁症状的健康个体的全基因组甲基化研究。
J Hum Genet. 2018 Mar;63(3):319-326. doi: 10.1038/s10038-017-0382-y. Epub 2018 Jan 5.
4
DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression.脑源性神经营养因子(BDNF)基因的 DNA 甲基化谱作为重度抑郁症的潜在诊断生物标志物。
PLoS One. 2011;6(8):e23881. doi: 10.1371/journal.pone.0023881. Epub 2011 Aug 30.
5
Methylome profiling of young adults with depression supports a link with immune response and psoriasis.对年轻抑郁症患者的甲基化组图谱分析支持其与免疫反应和银屑病有关联。
Clin Epigenetics. 2020 Jun 15;12(1):85. doi: 10.1186/s13148-020-00877-7.
6
DNA methylation of DLG4 and GJA-1 of human hippocampus and prefrontal cortex in major depression is unchanged in comparison to healthy individuals.与健康个体相比,重度抑郁症患者海马体和前额叶皮质中DLG4和GJA-1的DNA甲基化没有变化。
J Clin Neurosci. 2017 Sep;43:261-263. doi: 10.1016/j.jocn.2017.05.030. Epub 2017 Jun 20.
7
DNA Methylation Signatures of Depressive Symptoms in Middle-aged and Elderly Persons: Meta-analysis of Multiethnic Epigenome-wide Studies.中老年人群抑郁症状的 DNA 甲基化特征:多民族全基因组表观遗传学研究的荟萃分析。
JAMA Psychiatry. 2018 Sep 1;75(9):949-959. doi: 10.1001/jamapsychiatry.2018.1725.
8
DNA methylation and expression of stress related genes in PBMC of MDD patients with and without serious suicidal ideation.伴有和不伴有严重自杀意念的抑郁症患者外周血单核细胞中应激相关基因的DNA甲基化与表达
J Psychiatr Res. 2017 Jun;89:115-124. doi: 10.1016/j.jpsychires.2017.02.005. Epub 2017 Feb 16.
9
Parvalbumin Promoter Methylation Altered in Major Depressive Disorder.抑郁障碍中钙结合蛋白启动子甲基化改变。
Int J Med Sci. 2019 Aug 14;16(9):1207-1214. doi: 10.7150/ijms.36131. eCollection 2019.
10
Investigating DNA Methylation of SHATI/NAT8L Promoter Sites in Blood of Unmedicated Patients with Major Depressive Disorder.探讨未用药的重性抑郁障碍患者血液中 SHATI/NAT8L 启动子区域的 DNA 甲基化。
Biol Pharm Bull. 2020;43(7):1067-1072. doi: 10.1248/bpb.b19-01099.

引用本文的文献

1
Prediction of late-onset depression in the elderly Korean population using machine learning algorithms.使用机器学习算法预测韩国老年人群中的迟发性抑郁症。
Sci Rep. 2025 Jan 7;15(1):1196. doi: 10.1038/s41598-025-85157-1.
2
Deciphering Depression: Epigenetic Mechanisms and Treatment Strategies.解读抑郁症:表观遗传机制与治疗策略
Biology (Basel). 2024 Aug 20;13(8):638. doi: 10.3390/biology13080638.
3
Characterization and Comparative Analysis of Whole-Transcriptome Sequencing in High- and Low-Fecundity Chongming White Goat Ovaries during the Estrus Phase.发情期高繁殖力和低繁殖力崇明白山羊卵巢全转录组测序的表征及比较分析
Animals (Basel). 2024 Mar 22;14(7):988. doi: 10.3390/ani14070988.
4
DNA methylation and the opposing NMDAR dysfunction in schizophrenia and major depression disorders: a converging model for the therapeutic effects of psychedelic compounds in the treatment of psychiatric illness.精神分裂症和重度抑郁症中的 DNA 甲基化和相反的 NMDA 功能障碍:致幻化合物治疗精神疾病的疗效的汇聚模型。
Mol Psychiatry. 2023 Nov;28(11):4553-4567. doi: 10.1038/s41380-023-02235-4. Epub 2023 Sep 7.
5
Interferon signaling and hypercytokinemia-related gene expression in the blood of antidepressant non-responders.抗抑郁药无反应者血液中的干扰素信号传导及高细胞因子血症相关基因表达
Heliyon. 2023 Jan 16;9(1):e13059. doi: 10.1016/j.heliyon.2023.e13059. eCollection 2023 Jan.
6
The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders.DNA甲基化在神经系统疾病和神经退行性疾病进展中的作用以及使用DNA甲基化抑制剂作为此类疾病治疗药物的前景。
IBRO Neurosci Rep. 2022 Dec 12;14:28-37. doi: 10.1016/j.ibneur.2022.12.002. eCollection 2023 Jun.
7
Effects of pain and depression on the relationship between household solid fuel use and disability among middle-aged and older adults.疼痛和抑郁对中年及以上人群中家庭固体燃料使用与残疾之间关系的影响。
Sci Rep. 2022 Dec 8;12(1):21270. doi: 10.1038/s41598-022-25825-8.
8
DNA Methylation as a Therapeutic and Diagnostic Target in Major Depressive Disorder.DNA甲基化作为重度抑郁症的治疗和诊断靶点
Front Behav Neurosci. 2022 Mar 30;16:759052. doi: 10.3389/fnbeh.2022.759052. eCollection 2022.
9
Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder.早发性和成人期发作的重度抑郁症的多组学特征分析
J Pers Med. 2022 Mar 6;12(3):412. doi: 10.3390/jpm12030412.
10
Optimized protocol for the extraction of RNA and DNA from frozen whole blood sample stored in a single EDTA tube.从单个 EDTA 管中储存的冷冻全血样本中提取 RNA 和 DNA 的优化方案。
Sci Rep. 2021 Aug 23;11(1):17075. doi: 10.1038/s41598-021-96567-2.

本文引用的文献

1
A methylation study of long-term depression risk.长时程抑郁风险的甲基化研究。
Mol Psychiatry. 2020 Jun;25(6):1334-1343. doi: 10.1038/s41380-019-0516-z. Epub 2019 Sep 9.
2
Genome-wide profiling of DNA methylome and transcriptome in peripheral blood monocytes for major depression: A Monozygotic Discordant Twin Study.全基因组分析外周血单核细胞中 DNA 甲基化组和转录组在重度抑郁症中的变化:一项同卵双生双胞胎的研究。
Transl Psychiatry. 2019 Sep 2;9(1):215. doi: 10.1038/s41398-019-0550-2.
3
Epigenome-wide association study of depression symptomatology in elderly monozygotic twins.老年人单卵双胞胎抑郁症状的全基因组关联研究。
Transl Psychiatry. 2019 Sep 2;9(1):214. doi: 10.1038/s41398-019-0548-9.
4
What do DNA methylation studies tell us about depression? A systematic review.DNA 甲基化研究告诉了我们关于抑郁症的什么?一项系统性综述。
Transl Psychiatry. 2019 Feb 4;9(1):68. doi: 10.1038/s41398-019-0412-y.
5
Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer.重新审视二氢乳清酸脱氢酶作为癌症治疗靶点的作用。
Pharmacol Ther. 2019 Mar;195:111-131. doi: 10.1016/j.pharmthera.2018.10.012. Epub 2018 Oct 19.
6
Methylation of and in Relation to Treatment Response to Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder.创伤后应激障碍中与基于正念减压治疗反应相关的[具体物质]甲基化
Front Psychiatry. 2018 Sep 18;9:418. doi: 10.3389/fpsyt.2018.00418. eCollection 2018.
7
Integrated profiling of phenotype and blood transcriptome for stress vulnerability and depression.应激易感性和抑郁症的表型和血液转录组综合分析。
J Psychiatr Res. 2018 Sep;104:202-210. doi: 10.1016/j.jpsychires.2018.08.010. Epub 2018 Aug 6.
8
DNA Methylation Signatures of Depressive Symptoms in Middle-aged and Elderly Persons: Meta-analysis of Multiethnic Epigenome-wide Studies.中老年人群抑郁症状的 DNA 甲基化特征:多民族全基因组表观遗传学研究的荟萃分析。
JAMA Psychiatry. 2018 Sep 1;75(9):949-959. doi: 10.1001/jamapsychiatry.2018.1725.
9
DNA methylation and inflammation marker profiles associated with a history of depression.DNA 甲基化和炎症标志物谱与抑郁症病史相关。
Hum Mol Genet. 2018 Aug 15;27(16):2840-2850. doi: 10.1093/hmg/ddy199.
10
Epigenetic mechanisms of major depression: Targeting neuronal plasticity.重度抑郁症的表观遗传机制:针对神经元可塑性。
Psychiatry Clin Neurosci. 2018 Apr;72(4):212-227. doi: 10.1111/pcn.12621. Epub 2017 Dec 26.

成年发病型和晚发型抑郁症之间存在明显的表观遗传特征差异。

Distinct epigenetic signatures between adult-onset and late-onset depression.

机构信息

Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-kogushi, Ube, Yamaguchi, 755-8505, Japan.

Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), 4-1-8 Honcho, Kawaguchi, Saitama, 332-0012, Japan.

出版信息

Sci Rep. 2021 Jan 27;11(1):2296. doi: 10.1038/s41598-021-81758-8.

DOI:10.1038/s41598-021-81758-8
PMID:33504850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7840753/
Abstract

The heterogeneity of major depressive disorder (MDD) is attributed to the fact that diagnostic criteria (e.g., DSM-5) are only based on clinical symptoms. The discovery of blood biomarkers has the potential to change the diagnosis of MDD. The purpose of this study was to identify blood biomarkers of DNA methylation by strategically subtyping patients with MDD by onset age. We analyzed genome-wide DNA methylation of patients with adult-onset depression (AOD; age ≥ 50 years, age at depression onset < 50 years; N = 10) and late-onset depression (LOD; age ≥ 50 years, age at depression onset ≥ 50 years; N = 25) in comparison to that of 30 healthy subjects. The methylation profile of the AOD group was not only different from that of the LOD group but also more homogenous. Six identified methylation CpG sites were validated by pyrosequencing and amplicon bisulfite sequencing as potential markers for AOD in a second set of independent patients with AOD and healthy control subjects (N = 11). The combination of three specific methylation markers achieved the highest accuracy (sensitivity, 64%; specificity, 91%; accuracy, 77%). Taken together, our findings suggest that DNA methylation markers are more suitable for AOD than for LOD patients.

摘要

重度抑郁症(MDD)的异质性归因于这样一个事实,即诊断标准(例如 DSM-5)仅基于临床症状。血液生物标志物的发现有可能改变 MDD 的诊断。本研究的目的是通过根据发病年龄对 MDD 患者进行策略性亚型分类来确定 DNA 甲基化的血液生物标志物。我们分析了成年发病抑郁(AOD;年龄≥50 岁,抑郁发病年龄<50 岁;N=10)和晚发抑郁(LOD;年龄≥50 岁,抑郁发病年龄≥50 岁;N=25)患者与 30 名健康受试者的全基因组 DNA 甲基化。AOD 组的甲基化谱不仅与 LOD 组不同,而且更同质。通过焦磷酸测序和扩增子亚硫酸氢盐测序验证了六个确定的甲基化 CpG 位点,作为第二组独立的 AOD 患者和健康对照(N=11)中 AOD 的潜在标志物。三个特定甲基化标志物的组合实现了最高的准确性(灵敏度 64%,特异性 91%,准确性 77%)。总之,我们的研究结果表明,与 LOD 患者相比,DNA 甲基化标志物更适合 AOD。